Eko Analysis Software vs PMcardio

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 75/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Eko Devices
VS
by Powerful Medical

AI Verdict

Eko Analysis Software and PMcardio are adjacent competitors, both focusing on AI-powered cardiac diagnostics but with different primary data inputs. Eko leverages digital stethoscopes to analyze heart sounds and ECGs for conditions like murmurs and AFib, making it suitable for point-of-care screening during physical exams. PMcardio, on the other hand, specializes in interpreting 12-lead ECGs from various sources to detect a broader range of over 50 cardiac conditions, offering a more comprehensive ECG analysis tool.

Choose Eko Analysis Software if…

Choose Eko Analysis Software if you are a clinician seeking an AI-powered tool to enhance your physical examinations for early detection of cardiovascular diseases. This tool is ideal for integrating with digital stethoscopes to analyze heart sounds and ECGs, assisting in the identification of heart murmurs and atrial fibrillation at the point of care.

View Eko Analysis Software →

Choose PMcardio if…

Choose PMcardio if you require rapid, expert-level interpretation of 12-lead ECGs to assess over 50 cardiac conditions, including critical hidden heart attacks like STEMI/OMI and reduced LVEF. This platform is particularly well-suited for emergency medicine and other settings where quick and accurate ECG analysis is crucial for confident decision-making and optimizing patient triage.

View PMcardio →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Eko Analysis Software PMcardio
Pricing Freemium with subscription for full features Freemium
Deployment Cloud-based Mobile app (iOS and Android), Web platform, Enterprise integrations with EHR/CVIS and EMS systems
FDA Status 1 AI-estimated Pending AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Tie

Both tools offer mobile app deployments and freemium models, suggesting a focus on accessibility and ease of use for individual clinicians. Eko integrates with its digital stethoscopes for a streamlined physical exam, while PMcardio emphasizes rapid interpretation of existing ECGs. Without direct user experience comparisons, it's difficult to definitively pick a winner.

Clinical Value

PMcardio

PMcardio demonstrates a broader range of detection capabilities, assessing over 50 cardiac conditions from ECGs, including advanced features like STEMI/OMI detection with explainability and reduced LVEF detection. Eko focuses on heart murmurs and AFib detection through auscultation and ECGs. While both are clinically validated, PMcardio's wider diagnostic scope and explainable AI offer potentially greater clinical utility for ECG interpretation.

Pricing & Value

Tie

Both Eko Analysis Software and PMcardio offer freemium models with subscriptions for full features. Eko's pricing details mention Eko+ membership for full AI capabilities and telehealth livestreaming, while PMcardio offers a free plan with 5 ECG analyses per month and a Pro Plan for unlimited use and advanced features. The specific value proposition for each will depend on individual clinician or institutional needs and usage volume, making a definitive winner difficult without more detailed cost-benefit analysis for various use cases.

Enterprise Readiness

PMcardio

PMcardio explicitly lists 'Enterprise integrations with EHR/CVIS and EMS systems' as a deployment option and offers 'PMcardio for Organizations' with custom pricing and unlimited users/locations. Eko mentions secure cloud-based storage and HIPAA compliance, but PMcardio's stated enterprise-level integrations suggest a more robust offering for larger healthcare systems.

Innovation

PMcardio

PMcardio stands out with its 'ECGxplainu2122 - Visual AI Explainability with heatmaps' and 'Queen of Heartsu2122 - STEMI and OMI Detection,' which provides insights into the AI's decision-making process. While Eko's integration of AI with digital stethoscopes is innovative, PMcardio's explainable AI and broader range of advanced ECG interpretations demonstrate a higher degree of innovation in the AI diagnostic space.

Support & Docs

Tie

Both companies likely offer standard support and documentation, but specific details on the breadth and depth of these offerings are not extensively covered in the provided information or easily found through general web searches. PMcardio does have a 'Help Center' and 'FAQ' section, and Eko has a 'Help Center' and 'Support' section. Without more comparative information, it's not possible to declare a clear winner.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Eko Analysis Software PMcardio
Tool Name Eko Analysis Software PMcardio
Company Eko Devices Powerful Medical
Tagline Your new partner in precise, proactive heart and lung care. AI that reads ECGs in seconds
Regulatory Clearance FDA-cleared CE-certified
Key AI Detections Heart murmur detection, Atrial Fibrillation (AFib) detection, Normal sinus rhythm detection 50+ ECG findings (including STEMI/OMI, rhythms, reduced LVEF, conduction disorders), STEMI and OMI Detection, Reduced LVEF Detection, 36 core diagnoses (arrhythmias, conduction blocks, heart blocks, chamber hypertrophies)

Videos

Demos, reviews, and walkthroughs featuring Eko Analysis Software and PMcardio.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Eko Analysis Software integrates with Eko's digital stethoscopes and mobile app, allowing for recording, playback, and annotation of heart sounds and ECGs. It offers EHR integration to push PDF reports or anonymous URLs directly to the patient's chart, and enables single sign-on for telehealth sessions. PMcardio integrates with existing ECG systems, EHR/CVIS, and EMS systems, aiming for seamless workflow alignment and real-time alerts. It can also export detailed PDF reports for integration into EHRs.
Eko's AI for AFib detection has a sensitivity of 99% and specificity of 97% when analyzing 1-lead ECG from the Eko DUO stethoscope. For heart murmur detection, Eko's algorithm has a sensitivity of 90.0% and specificity of 91.4% (excluding grade 1 murmurs), and for moderate-to-severe aortic stenosis, it shows 93.2% sensitivity and 86.0% specificity. PMcardio's AI for major ECG abnormalities has a sensitivity of 86% and specificity of 92%, with near-perfect accuracy for atrial fibrillation (97% sensitivity, 99% specificity). Its Queen of Heartsu2122 platform for STEMI detection has shown 92% sensitivity and 81% specificity, outperforming standard processes.
Eko Analysis Software is designed for cardiology, emergency medicine, and internal medicine, focusing on early detection of heart murmurs, atrial fibrillation, and normal sinus rhythm. It also has capabilities for detecting reduced left ventricular ejection fraction (LVEF). PMcardio is suitable for cardiology, emergency medicine, and internal medicine, interpreting ECGs to assess over 50 cardiac conditions, including STEMI/OMI, various rhythms, reduced LVEF, and conduction disorders.
Eko's platform is designed to enhance clinical expertise and provide step-by-step guidance for exams, suggesting a focus on ease of use for frontline providers. PMcardio emphasizes speed and simplicity, aiming to provide instant AI-powered ECG analysis to clinicians. PMcardio also offers visual AI explainability with heatmaps (ECGxplainu2122) to help clinicians understand the AI's diagnostic rationale, which could aid in the learning process.
PMcardio for Organizations offers full audit trails for every pathway action, supporting QA, audits, and protocol optimization. For individual users, the Pro Plan includes detailed ECG report history for documentation and audits. Eko's platform focuses on automatic record-keeping and secure cloud-based storage of recordings.
PMcardio for Organizations is built for health systems, offering a unified cardiac AI platform that scales across campuses and care settings with one integration and security review. It supports real-time coordination and performance tracking across sites. Eko's platform is also designed to scale detection capabilities for entire teams or health systems in various settings.
PMcardio is SOC 2 Type II and ISO 27001 certified, ensuring secure data handling and information security management. It also supports regional data residency and role-based access control. Eko Cloud is SOC2 certified, ensuring data is always encrypted in transit and at rest.

Backers

Who funded each tool's parent company.

Eko Analysis Software

PMcardio

AI Tool Finder
AI-powered search. Results may not be comprehensive.